Fatty acids fight cancer spread

April 10, 2012, University of Sydney
Professor Michael Murray and Dr Sarah Cui were part of the team who made the discovery.

Tiny agents found in omega-3 could potentially be used to block the path of primary cancer tumours, preventing the advance to secondary stage cancers according to pharmacy researchers at the University of Sydney.

Investigators in the Pharmacogenomics and Drug Development Group of the Faculty of Pharmacy are using to gauge the blocking capacity of the omega-3 agents called epoxides on cancer cell movement.

Dr. Michael Murray, Professor of Pharmogenetics at the University, says a major life-threatening consequence of malignant is metastasis where the disease has spread to distant sites (or tissues) and at present there are no treatments.

He led his team to the discovery of the anti-metastatic actions of epoxides which are produced within the body from omega-3 polyunsaturated fatty acids. The groundbreaking work has led Murray and his Drug Development Group deeper into the molecular structure of the omega-3 agents.

Professor Murray says: "These agents are a bit like frontline soldiers blocking the assault of an invading army and now we want to advance our research which was published late last year and apply it to .

"We know that epidemiological studies have reported that dietary intake of omega-3 including eicosapentaenoic and docosahexaenoic acids, decrease the risk of certain cancers. And many of us are including sources of omega-3 such as tuna and salmon in our diet as a precaution.

"The major objective of our new project is to speed the development of anti-metastatic agents based on omega-3 epoxides and trial their effectiveness in vivo on breast cancer tissue.

"Longer term we are aiming to develop a completely new class of anti-metastatic drugs designed to inhibit the spread of primary cancers," Murray says.

Although not all experts agree, women who eat foods rich in omega-3 fatty acids over many years may be less likely to develop breast cancer. More research is needed to understand the effect that omega-3 fatty acids may have on the prevention of breast cancer says Murray.

Research has also shown that omega-3 fatty acids reduce inflammation and may help lower risk of chronic diseases such as heart disease and arthritis.

Explore further: Researchers find that fish oil boosts responses to breast cancer drug tamoxifen

Related Stories

Researchers find that fish oil boosts responses to breast cancer drug tamoxifen

April 6, 2011
Breast cancer is the second most common cancer among women, with more than 200,000 women diagnosed each year. Being exposed to estrogen over a long period of time is one factor that can increase a woman's risk of developing ...

Recommended for you

Modular gene enhancer promotes leukemia and regulates effectiveness of chemotherapy

January 18, 2018
Every day, billions of new blood cells are generated in the bone marrow. The gene Myc is known to play an important role in this process, and is also known to play a role in cancer. Scientists from the German Cancer Research ...

Researchers find a way to 'starve' cancer

January 18, 2018
Researchers at Vanderbilt University Medical Center (VUMC) have demonstrated for the first time that it is possible to starve a tumor and stop its growth with a newly discovered small compound that blocks uptake of the vital ...

Researchers develop swallowable test to detect pre-cancerous Barrett's esophagus

January 17, 2018
Investigators at Case Western Reserve University School of Medicine and University Hospitals Cleveland Medical Center have developed a simple, swallowable test for early detection of Barrett's esophagus that offers promise ...

Scientists zoom in to watch DNA code being read

January 17, 2018
Scientists have unveiled incredible images of how the DNA code is read and interpreted—revealing new detail about one of the fundamental processes of life.

Presurgical targeted therapy delays relapse of high-risk stage 3 melanoma

January 17, 2018
A pair of targeted therapies given before and after surgery for melanoma produced at least a six-fold increase in time to progression compared to standard-of-care surgery for patients with stage 3 disease, researchers at ...

Dulling cancer therapy's double-edged sword

January 17, 2018
Researchers have discovered that killing cancer cells can actually have the unintended effect of fueling the proliferation of residual, living cancer cells, ultimately leading to aggressive tumor progression.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.